Literature DB >> 2665439

Synthetic T and B cell recognition sites: implications for vaccine development.

D R Milich1.   

Abstract

Mesh：

Substances：

Year:  1989        PMID： 2665439     DOI： 10.1016/s0065-2776(08)60694-x

Source DB:  PubMed          Journal:  Adv Immunol        ISSN： 0065-2776            Impact factor:   3.543


× No keyword cloud information.
  21 in total

1.  Enhancement of the antibody response to flavivirus B-cell epitopes by using homologous or heterologous T-cell epitopes.

Authors:  J T Roehrig; A J Johnson; A R Hunt; B J Beaty; J H Mathews
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

2.  Analysis of human T-cell epitopes in the 19,000 MW antigen of Mycobacterium tuberculosis: influence of HLA-DR.

Authors:  A Faith; C Moreno; R Lathigra; E Roman; M Fernandez; S Brett; D M Mitchell; J Ivanyi; A D Rees
Journal:  Immunology       Date:  1991-09       Impact factor: 7.397

3.  Conserved MHC class I-presented dengue virus epitopes identified by immunoproteomics analysis are targets for cross-serotype reactive T-cell response.

Authors:  James S Testa; Vivekananda Shetty; Gomathinayagam Sinnathamby; Zacharie Nickens; Julie Hafner; Shivali Kamal; Xianchao Zhang; Marti Jett; Ramila Philip
Journal:  J Infect Dis       Date:  2012-01-13       Impact factor: 5.226

4.  Mapping of B-cell epitopes of the human hepatitis B virus X protein.

Authors:  M Stemler; T Weimer; Z X Tu; D F Wan; M Levrero; C Jung; G R Pape; H Will
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

5.  Neutralizing antibodies to all seven serotypes of foot-and-mouth disease virus elicited by synthetic peptides.

Authors:  M J Francis; G Z Hastings; B E Clarke; A L Brown; C R Beddell; D J Rowlands; F Brown
Journal:  Immunology       Date:  1990-02       Impact factor: 7.397

6.  Human T- and B-cell epitopes of E1 glycoprotein of rubella virus.

Authors:  H Chaye; D Ou; P Chong; S Gillam
Journal:  J Clin Immunol       Date:  1993-03       Impact factor: 8.317

7.  Identification of T-cell epitopes on E2 protein of rubella virus, as recognized by human T-cell lines and clones.

Authors:  D Ou; P Chong; Y Choi; P McVeigh; W A Jefferies; G Koloitis; A J Tingle; S Gillam
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

8.  Induction of antibody responses that neutralize human T-cell leukemia virus type I infection in vitro and in vivo by peptide immunization.

Authors:  Y Tanaka; R Tanaka; E Terada; Y Koyanagi; N Miyano-Kurosaki; N Yamamoto; E Baba; M Nakamura; H Shida
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

9.  Immune response to hepatitis B virus surface antigen peptides during HBV infection.

Authors:  A Mishra; H Durgapal; V Manivel; S K Acharya; K V Rao; S K Panda
Journal:  Clin Exp Immunol       Date:  1992-11       Impact factor: 4.330

10.  Total chemical synthesis, characterization, and immunological properties of an MHC class I model using the TASP concept for protein de novo design.

Authors:  G Tuchscherer; C Servis; G Corradin; U Blum; J Rivier; M Mutter
Journal:  Protein Sci       Date:  1992-10       Impact factor: 6.725
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.